 WOBURN, Mass., Sept. 29, 2021 GLOBE NEWSWIRE -- SeqLL Inc. SeqLL or the Company NASDAQ:SQL; SQLLW, a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple omics fields, today announced the closing of the sale of an additional 189,000 shares of common stock at the initial public offering price of 4.24 per share, pursuant to the partial exercise of the underwriters over-allotment option, in connection with its initial public offering that closed on August 31, 2021, resulting in gross proceeds of approximately 801,360. After giving effect to the exercise of the over-allotment option, the total gross proceeds of the initial public offering increased to approximately 13,810,950. 